Skip to main content
Premium Trial:

Request an Annual Quote

Bruker's Q1 Revenues Up 21 Percent

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker today reported first-quarter 2010 revenue growth of 21 percent, with strong sales from both its Bruker Scientific Instruments (BSI) segment and Bruker Energy & Supercon Technologies (BEST) segment.

The Billerica, Mass.-based firm generated total revenues of $277.7 million for the three months ended March 31, compared to $230.5 million for the first quarter of 2009. Its products revenues were $244 million versus $202.2 million for Q1 2009, while its service revenues were $31.5 million versus $26.9 million. Its "other" revenues were $2.2 million compared to $1.4 million for Q1 2009.

Bruker said that excluding the effects of foreign currency, its Q1 revenues rose around 12 percent.

By segment, BSI brought in $260.3 million compared to $223.6 million for the prior year's first quarter, while BEST's revenues more than doubled to $20.7 million from $8.1 million.

Bruker beat analysts' consensus estimate for revenues of $256.8 million.

"All four operating divisions in our BSI segment delivered double-digit growth year-over-year, and our BEST segment had triple-digit growth for the second quarter in a row," Bruker President and CEO Frank Laukien, said in a statement. "The industrial and applied markets continued to improve gradually during the first quarter, and overall we recorded healthy new order bookings, including more than $10 million in additional US stimulus orders, all of which contributed to strong backlog at the end of the first quarter."

The firm's profit for the quarter nearly doubled to $16.1 million, or $.10 per share, from $8.4 million, or $.05 per share. It beat Wall Street's expectations of $.08.

Its R&D expenses increased 13 percent to $32.8 million from $29.1 million, while its SG&A spending increased 12 percent to $66.1 million from $58.9 million.

Bruker finished the quarter with $206.6 million in cash, cash equivalents, and restricted cash.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.